alcohol dependence
Information
- Disease name
- alcohol dependence
- Disease ID
- DOID:0050741
- Description
- "A substance dependence that is characterized by tolerance, withdrawal symptoms, increasing use, persistent desire to decrease consumption, time spent obtaining or recovering from alcohol caused by a physical and psychological dependence on alcohol." [url:https\://en.wikipedia.org/wiki/Alcohol_dependence]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04107051 | Active, not recruiting | Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients With Alcohol Dependence | October 1, 2019 | March 31, 2024 | |
| NCT04581499 | Active, not recruiting | N/A | Tech-Enabled CM for AUD at Scale | January 1, 2021 | April 2024 |
| NCT03842670 | Active, not recruiting | N/A | Neurocognitive and Neurobehavioral Mechanisms of Change Following Psychological Treatment for Alcohol Use Disorder | November 14, 2018 | September 30, 2024 |
| NCT03481049 | Active, not recruiting | N/A | Individualizing Incentives for Alcohol in the Severely Mentally Ill | May 5, 2018 | August 31, 2024 |
| NCT00106093 | Completed | Alcoholism Assessment and Treatment | March 16, 2005 | September 8, 2015 | |
| NCT00106106 | Completed | Phase 2 | Acamprosate to Reduce Symptoms of Alcohol Withdrawal | March 2005 | July 2010 |
| NCT00114686 | Completed | Phase 3 | Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder | January 2006 | April 2007 |
| NCT00183105 | Completed | Phase 3 | ASAP Study - Hospital-Based Brief Intervention for Alcohol Problems | February 2001 | April 2006 |
| NCT00183118 | Completed | Phase 1/Phase 2 | Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment) | October 2004 | December 2005 |
| NCT00183131 | Completed | Phase 2 | The iHealth Study in College Students | October 2004 | November 2004 |
| NCT00183144 | Completed | Phase 2 | A Therapeutic Workplace for Alcohol Dependence | November 2001 | April 2006 |
| NCT00183196 | Completed | Phase 3 | Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone | January 2003 | June 2009 |
| NCT00183222 | Completed | Phase 2 | Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking | May 2005 | December 2005 |
| NCT00183235 | Completed | Phase 2 | Aripiprazole Effects on Alcohol Reactivity and Consumption | June 2005 | February 2006 |
| NCT00194103 | Completed | Phase 3 | Effectiveness of Extended Telephone Monitoring | May 2004 | April 2010 |
| NCT00217984 | Completed | N/A | Intensive Intervention for Smokers - 6 | July 2006 | June 2010 |
| NCT00218569 | Completed | Phase 2 | Combined Treatment for Cocaine-Alcohol Dependence - 1 | April 2003 | December 2007 |
| NCT00223275 | Completed | Phase 4 | Naltrexone for Bipolar Disorder and Alcohol Dependence | May 2005 | September 2007 |
| NCT00226694 | Completed | N/A | Alcohol and Gender Effects on Stress Circuit Function | September 2003 | August 2012 |
| NCT00226720 | Completed | N/A | Outpatient Versus Inpatient Detoxification Program for Alcohol Dependent Patients Seeking Abstinence: The IN/OUT Study | September 2002 | November 2004 |
| NCT00246441 | Completed | Phase 4 | Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism | March 2002 | February 2008 |
| NCT00262639 | Completed | Phase 2/Phase 3 | Prometa Protocol for Alcohol Dependence | December 2005 | March 2008 |
| NCT00265512 | Completed | N/A | LINK: Aftercare Monitoring Project | November 2006 | January 2010 |
| NCT00278447 | Completed | Phase 3 | Addiction Health Evaluation And Disease Management (AHEAD) Study | April 2006 | April 2012 |
| NCT00280813 | Completed | N/A | Alcohol Use Disorders in Schizophrenia | March 2004 | May 2007 |
| NCT00298792 | Completed | Phase 1 | Individualized Treatment Program for Alcohol Problems | January 2006 | April 2008 |
| NCT00300742 | Completed | Phase 2 | Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered Individuals | March 2006 | July 2008 |
| NCT00302133 | Completed | Phase 1/Phase 2 | Optimizing Pharmacotherapy for Bipolar Alcoholics | May 2006 | July 2013 |
| NCT00310427 | Completed | Phase 2 | Effect of LY686017 on Alcohol Craving | March 2006 | March 2008 |
| NCT00330174 | Completed | Phase 4 | Acamprosate in Alcoholics With Comorbid Anxiety or Depression | April 2006 | September 2010 |
| NCT00330486 | Completed | Phase 1/Phase 2 | Open Label Trial of Acamprosate in Bipolar Alcoholics | April 2006 | June 2007 |
| NCT00366626 | Completed | Phase 4 | Effectiveness of Naltrexone Versus Placebo to Reduce Craving for Alcohol With Evaluation of Genetic Variability. | April 2006 | January 2010 |
| NCT00369408 | Completed | Phase 4 | Targeted Naltrexone for Problem Drinkers | June 2003 | March 2008 |
| NCT00381043 | Completed | Phase 4 | Study of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine Clinic | August 2006 | July 2008 |
| NCT00382642 | Completed | Phase 3 | Pharmacological Treatment for Alcoholism | June 2006 | December 2009 |
| NCT00391716 | Completed | Phase 2 | Gabapentin Treatment of Alcohol Dependence | February 2004 | February 2010 |
| NCT00408161 | Completed | N/A | Contingency Management for Chronic Recidivist Alcohol-Dependent Patients | August 2003 | September 2008 |
| NCT00419315 | Completed | Phase 4 | A Randomized Clinical Trial of Alcohol Care Management | August 2007 | July 2011 |
| NCT00423904 | Completed | Phase 2 | Brief Alcohol Intervention in General Hospitals | October 2001 | August 2005 |
| NCT00424112 | Completed | Motivation in Alcohol Treatment Facilities | October 2004 | September 2006 | |
| NCT02478489 | Completed | Phase 4 | Alcohol Disorder hOsPital Treatment Trial | June 2016 | October 2020 |
| NCT00000456 | Completed | Phase 4 | Behavioral Therapy Plus Naltrexone for Alcoholism | September 1992 | August 2002 |
| NCT00006204 | Completed | Phase 4 | Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine) | March 2000 | January 2006 |
| NCT00006489 | Completed | Phase 4 | Treatment for Alcoholism and Post-Traumatic Stress Disorder (Naltrexone) | December 2000 | February 2011 |
| NCT01751386 | Completed | Phase 2 | Baclofen for Treating Anxiety and Alcoholism | December 3, 2012 | August 17, 2016 |
| NCT01758523 | Completed | Phase 4 | Dutasteride Treatment for the Reduction of Heavy Drinking in Men | January 2013 | February 28, 2018 |
| NCT01828866 | Completed | N/A | Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients | September 2013 | August 2016 |
| NCT01842503 | Completed | Phase 1/Phase 2 | Safety and Pharmacodynamic Study of GET 73 in Alcohol Dependent | November 2014 | November 2018 |
| NCT01847469 | Completed | Phase 2 | Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence | June 2013 | January 1, 2019 |
| NCT01856712 | Completed | Phase 3 | Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence | May 2013 | January 2016 |
| NCT01883089 | Completed | N/A | Ambivalence Model of Craving: Re-examining the Drinking-craving Relationship | January 2015 | May 2017 |
| NCT01893827 | Completed | Phase 4 | Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care | June 2014 | October 3, 2018 |
| NCT01941693 | Completed | N/A | A Randomized Controlled Trial of Structured Stepped-care Intervention for Psychiatric Comorbidity | March 2007 | March 2013 |
| NCT01942954 | Completed | N/A | Health Mobile Cognitive Stimulation in Alcohol Use Disorder | October 2012 | July 2021 |
| NCT01969617 | Completed | Phase 1 | Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge | November 2013 | |
| NCT01991704 | Completed | Incubation of Alcohol Craving During Abstinence | October 2011 | October 2013 | |
| NCT02030093 | Completed | Telephone-Based Continuing Care for Alcohol Dependence | December 9, 2013 | January 12, 2017 | |
| NCT02039349 | Completed | Phase 1 | A Novel Compound for Alcoholism Treatment | January 3, 2014 | December 24, 2017 |
| NCT02056535 | Completed | Phase 2 | Screening and Brief Intervention in the ED Among Mexican-origin Young Adults | May 2010 | October 2013 |
| NCT02061293 | Completed | Phase 2 | A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence | June 2014 | July 30, 2021 |
| NCT02074735 | Completed | Phase 4 | Citicoline for Alcohol Dependence | April 2014 | November 2016 |
| NCT02087358 | Completed | Alcohol Consumption and Stress at Patients Alcohol-dependants | July 2014 | December 2017 | |
| NCT02090504 | Completed | Phase 4 | Comparative Study of Gamma-hydroxy Butyrate Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome | February 2002 | May 2009 |
| NCT02107352 | Completed | Effect of Anti-craving Medication on Cognitive Functions in Alcohol Dependence: an ERP Study | December 1, 2013 | January 29, 2018 | |
| NCT02112396 | Completed | N/A | Community Reinforcement and Family Training (CRAFT) for Treatment-resistant Individuals With Alcohol Use Disorders | August 2008 | June 2011 |
| NCT02141789 | Completed | N/A | Outpatient Psychotherapeutic Treatment for Alcohol Dependent Individuals With Comorbid Psychiatric Disorders | November 2014 | March 2018 |
| NCT02146963 | Completed | Study of the BDNF-Val66Met Polymorphism in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal | May 2014 | April 2016 | |
| NCT02173041 | Completed | N/A | Impact of Prevention Awareness Group (PAG) on Treatment Attendance and Drug Abstinence Among Substance User | August 2014 | April 2015 |
| NCT02179749 | Completed | Phase 2 | Mifepristone Treatment of Alcohol Use Disorder | September 2014 | November 6, 2019 |
| NCT02187211 | Completed | Phase 1 | Minocycline's Effects on Alcohol Responses in Humans | July 1, 2015 | November 1, 2018 |
| NCT02187224 | Completed | Phase 2/Phase 3 | Progesterone Effect on Individuals Diagnoses With AD and PTSD. | September 1, 2016 | September 8, 2021 |
| NCT02193204 | Completed | N/A | Chronic Alcohol, Stress Inflammatory Response and Relapse Risk | September 2011 | July 2015 |
| NCT02197598 | Completed | Phase 4 | Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use | September 2014 | |
| NCT02210195 | Completed | Phase 2 | Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence | September 4, 2014 | December 19, 2016 |
| NCT02247388 | Completed | N/A | Automated Bilingual Computerized Alcohol Screening and Intervention in Latinos (AB-CASI) | October 2014 | April 30, 2020 |
| NCT02251912 | Completed | Phase 2 | Oxytocin Treatment of Alcohol Dependence | July 2015 | September 2016 |
| NCT02275611 | Completed | Phase 2 | Oxytocin Treatment of Alcohol Dependence | January 2013 | March 2014 |
| NCT02315885 | Completed | N/A | Biomarkers to Measure Treatment Response for Alcohol Dependence | July 2015 | December 31, 2019 |
| NCT02364947 | Completed | Phase 3 | A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial) | February 9, 2015 | July 30, 2016 |
| NCT02377726 | Completed | N/A | Anonymous Treatment on the Internet for Alcohol Dependence: A Randomised, Controlled Trial | April 1, 2015 | November 30, 2019 |
| NCT02382276 | Completed | Phase 3 | A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence | July 13, 2015 | January 18, 2017 |
| NCT02435381 | Completed | Phase 1/Phase 2 | Carisbamate as a Potential Treatment for Alcohol Dependence | February 2013 | September 30, 2013 |
| NCT02438969 | Completed | Epi-Genetic Modulators of Fear Extinction in Alcohol Dependence | August 13, 2015 | December 31, 2022 | |
| NCT02445339 | Completed | Phase 4 | Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users | July 2015 | February 8, 2019 |
| NCT02446067 | Completed | N/A | Cerebral Hemodynamics With rTMS in Alcohol Dependence | March 2010 | May 2011 |
| NCT00000451 | Completed | Phase 2 | Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline) | January 2003 | November 2005 |
| NCT02486900 | Completed | N/A | Neurofeedback & Alcohol Dependence | September 2015 | August 2018 |
| NCT02492581 | Completed | Use of Selincro and Impact on Usual Practice | February 2016 | April 2018 | |
| NCT02501057 | Completed | N/A | Reducing Alcohol Dependence Among HIV-Positive Individuals | August 2016 | June 2020 |
| NCT02539511 | Completed | Phase 2/Phase 3 | Glutamatergic Modulation of Disordered Alcohol Use | July 2015 | December 2017 |
| NCT02557815 | Completed | Phase 3 | Changing the Vulnerable Brain: A Neuromodulation Study in Alcohol Dependence | February 2012 | |
| NCT02564991 | Completed | Study of Structural Imaging | February 29, 2016 | March 18, 2020 | |
| NCT02603471 | Completed | N/A | Cell Phone Technology Targeting ART and Naltrexone Adherence and Alcohol Use | July 2014 | December 2016 |
| NCT02616094 | Completed | N/A | Multimodal Neuroimaging of Stress and Reward Cues to Assess Alcoholism Risk and Relapse | November 2015 | June 30, 2022 |
| NCT02634476 | Completed | N/A | Can Cognitive-bias Modification Training During Inpatient Alcohol Detoxification Reduce Relapse Rates Post-discharge? | June 2014 | February 2016 |
| NCT02650180 | Completed | N/A | Usability Study for SOBERLINK System | December 2015 | March 2016 |
| NCT02664727 | Completed | N/A | Effects of Acute Exercise on Various Parameters in Individuals With Alcohol Use Disorders | January 2014 | June 2014 |
| NCT02679469 | Completed | Phase 1 | A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male Subjects | February 2016 | March 2016 |
| NCT02705898 | Completed | N/A | Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women | September 2015 | July 31, 2019 |
| NCT02862093 | Completed | N/A | Transcranial Magnetic Stimulation in Alcohol Use Disorder | January 2010 | August 2015 |
| NCT02888002 | Completed | N/A | Internet-based vs Face-to-face Treatment for Alcohol Dependence | December 1, 2015 | March 30, 2020 |
| NCT02901041 | Completed | Phase 3 | Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism | September 21, 2017 | January 4, 2022 |
| NCT02958280 | Completed | N/A | A Tailored Physical Activity Smartphone App for Patients With Alcohol Dependence | November 2016 | July 30, 2022 |
| NCT02968537 | Completed | N/A | Learning to Resist the Urge: Inhibition Training in Abstinent Patients With Alcohol Use Disorders | December 2016 | July 2020 |
| NCT03010917 | Completed | Phase 1 | Fish Oil vs. Placebo on Subjective Effects of Alcohol | March 2, 2017 | September 8, 2021 |
| NCT03238859 | Completed | Phase 2 | 10 Days of Theta Burst Stimulation as a Tool to Treat Cocaine Dependence | August 1, 2016 | June 7, 2019 |
| NCT03278821 | Completed | N/A | The Self Match Study: A Study of Informed Choice in the Treatment of Addiction | May 1, 2017 | January 29, 2021 |
| NCT03338361 | Completed | N/A | Research on the Efficacy of the "T.O.P. Computer Training" Procedure in the Treatment of Alcohol Dependence | October 26, 2017 | February 29, 2020 |
| NCT03340051 | Completed | N/A | Remote Alcohol Monitoring and Episodic Thinking | September 21, 2017 | October 3, 2019 |
| NCT03493958 | Completed | N/A | RCT of Web-Based Behavioral Sleep Intervention for Individuals With Alcohol Use Disorder | March 5, 2019 | November 30, 2022 |
| NCT03548714 | Completed | Phase 1 | Clinical Trial to Evaluate the Safety of PT150 (Formerly ORG34517) When it is Taken Concurrently With Alcohol | September 1, 2018 | July 15, 2019 |
| NCT03663374 | Completed | Phase 3 | Efficacy and Safety Evaluating Study of Odelepran for the Use in Patient With Alcohol Dependence | November 18, 2014 | May 14, 2016 |
| NCT03696888 | Completed | N/A | Skills-training for Reducing Risky Alcohol Use in App Form | December 7, 2018 | August 15, 2020 |
| NCT03732248 | Completed | Phase 1 | Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders | July 12, 2018 | January 20, 2020 |
| NCT04007042 | Completed | Validation of a Short Questionnaire (SSI) for Sleep Disorders in Patients With Alcohol | January 15, 2012 | January 15, 2013 | |
| NCT04167306 | Completed | Phase 2 | Varenicline and Bupropion for Alcohol Use Disorder | March 4, 2019 | December 15, 2022 |
| NCT04223154 | Completed | N/A | Effect of Theta Burst Stimulation on Alcohol Cue Reactivity | August 26, 2020 | April 16, 2021 |
| NCT04648423 | Completed | Phase 4 | Evaluation of the Efficacy of Sodium Oxybate in the Long-term Maintenance of Abstinence in Alcoholic Patients | July 23, 2001 | January 2012 |
| NCT00435435 | Completed | Phase 4 | Comparative Trial Of Disulfiram, Naltrexone And Acamprosate In The Treatment Of Alcohol Dependence | September 2000 | April 2005 |
| NCT00452543 | Completed | Phase 4 | Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism | March 2007 | May 2010 |
| NCT00453609 | Completed | Phase 4 | Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI) | April 2007 | October 2008 |
| NCT00453804 | Completed | Phase 4 | Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI) | July 2006 | June 2007 |
| NCT00457197 | Completed | Phase 4 | Quetiapine for Bipolar Disorder and Alcohol Dependence | March 2007 | July 2011 |
| NCT00463346 | Completed | Phase 3 | Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism | September 2006 | July 2015 |
| NCT00466661 | Completed | Phase 4 | Acamprosate vs. Placebo in Bipolar Alcoholics | April 2007 | February 2010 |
| NCT00501631 | Completed | Phase 3 | ALK21-014: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) After Enforced Abstinence | July 2007 | March 2011 |
| NCT00511836 | Completed | Phase 4 | ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults | July 2007 | October 2009 |
| NCT00513708 | Completed | N/A | Facilitating Aftercare for Alcohol Detox Patients | July 2007 | August 2008 |
| NCT00523133 | Completed | Phase 2 | Research on Individualized Treatment for Alcoholism | September 2000 | July 2005 |
| NCT00563797 | Completed | Phase 3 | Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence | August 2007 | July 2014 |
| NCT00572117 | Completed | Phase 4 | Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder | August 2007 | July 2014 |
| NCT00579267 | Completed | Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID) | February 2004 | January 2008 | |
| NCT00585780 | Completed | Phase 1/Phase 2 | Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse | September 2009 | May 13, 2019 |
| NCT00595556 | Completed | Phase 4 | Zonisamide vs. Placebo in the Treatment of Alcohol Dependence | July 2006 | May 2009 |
| NCT00596960 | Completed | N/A | Study of the Effects of Motivational Enhancement Therapy on Alcohol Use in Chronic Hepatitis C Patients | November 2008 | July 2012 |
| NCT00607620 | Completed | N/A | Disseminating Organizational SBI Services at Trauma Centers | September 2008 | September 2013 |
| NCT00614328 | Completed | Phase 1 | Combination of Naltrexone and Baclofen for Alcohol Dependence:A Pilot Study. | July 2007 | January 2010 |
| NCT00619255 | Completed | N/A | Adolescent Trauma Recovery and Stress Disorders Collaborative Care (ATRSCC) Model Program Trial | March 1, 2008 | June 1, 2014 |
| NCT00620750 | Completed | Phase 4 | Extended-release Naltrexone for Alcohol Dependence in Primary Care | July 2007 | February 2010 |
| NCT00635102 | Completed | N/A | Glycine and Oral D-Cycloserine in Alcoholic Patients and Healthy Subjects | October 1997 | February 2008 |
| NCT00639288 | Completed | Phase 2/Phase 3 | Modification of Cognitive Processing Therapy (CPT-C) for PTSD and Alcohol Dependence | March 2008 | April 2015 |
| NCT00665249 | Completed | N/A | Project Motion, A Study of Motivational Interviewing to Reduce Heavy or Problematic Drinking | April 2008 | July 2009 |
| NCT00667771 | Completed | Early Phase 1 | The Effect of Naltrexone on Alcohol Craving and on Brain Activity During Alcohol Infusion | April 22, 2008 | April 4, 2011 |
| NCT00667875 | Completed | Phase 2 | An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence | April 2008 | May 2011 |
| NCT00678457 | Completed | Phase 2 | Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical Trial | January 2007 | May 2008 |
| NCT00706901 | Completed | N/A | Impact of Group Motivational Interviewing and In-Home-Messaging-Devices for Dually Diagnosed Veterans | May 3, 2010 | September 30, 2013 |
| NCT00721526 | Completed | Phase 4 | Disulfiram Combined With Lorazepam for Alcohol Dependence and Anxiety Disorder | August 2009 | August 2012 |
| NCT00727103 | Completed | Phase 4 | Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia | July 2008 | May 2011 |
| NCT00744055 | Completed | Phase 3 | Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD). | January 2009 | October 2014 |
| NCT00744588 | Completed | Stress, Hypothalamic-pituitary-adrenal (HPA) Dysfunction, and Relapse in Alcoholism | August 2007 | March 2012 | |
| NCT00746785 | Completed | Phase 3 | A New Pharmacotherapy for Alcohol Dependence: Olanzapine | September 2002 | September 2011 |
| NCT00758277 | Completed | Phase 3 | Efficacy and Safety of Levetiracetam in Prevention of Alcohol Relapse in Recently Detoxified Alcohol Dependent Patients | May 2007 | December 2009 |
| NCT00777062 | Completed | Phase 2 | VIVITROL as a Treatment for Cocaine and Alcohol Dependence | July 2009 | September 2013 |
| NCT00792519 | Completed | Phase 1 | Cognitive Behavioral Treatment to Reduce Alcohol Use Among HIV-Infected Kenyans | February 2009 | December 2010 |
| NCT00800319 | Completed | Phase 1 | ALK33-001: A Study of RDC-0313 Administered to Healthy Adults | December 2008 | June 2009 |
| NCT00802035 | Completed | Phase 1 | ALK29-002: A Study of Baclofen Formulations in Healthy Adults | November 2008 | February 2009 |
| NCT00802412 | Completed | Phase 2 | Topiramate to Aid Smoking Cessation in Alcohol Dependent Men | January 2009 | June 2015 |
| NCT00804570 | Completed | Phase 2 | A Study for the Treatment of Alcohol Dependence | November 2008 | February 2010 |
| NCT00805441 | Completed | Phase 2 | A Study in the Treatment of Alcohol Dependence. | December 2008 | July 2009 |
| NCT00811720 | Completed | Phase 3 | Efficacy of Nalmefene in Patients With Alcohol Dependence | December 2008 | November 2010 |
| NCT00811941 | Completed | Phase 3 | Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence | March 2009 | November 2010 |
| NCT00812461 | Completed | Phase 3 | Efficacy of Nalmefene in Patients With Alcohol Dependence | March 2009 | April 2011 |
| NCT00831272 | Completed | Phase 4 | Pharmacogenetic Response to Naltrexone For Alcohol Dependence | January 5, 2009 | January 15, 2014 |
| NCT00842036 | Completed | Phase 2 | CRAFT Behavior Therapy: Treatment Entry Component | January 2006 | December 2009 |
| NCT00845208 | Completed | N/A | Network Support for Treatment of Alcohol Dependence | March 2002 | February 2008 |
| NCT00846859 | Completed | Phase 2 | Does Varenicline Influence Alcohol Consumption in Alcohol Dependent Individuals? | March 2009 | January 2011 |
| NCT00851669 | Completed | Phase 2 | The MEADOW PROJECT (Mending the Effects of Alcohol and Depression on Women) and The Bridge Program (Connecting Recovery Treatment and Behavioral Health) | April 2009 | July 2013 |
| NCT00873535 | Completed | N/A | Effect of Varenicline on Reactivity to Smoking and Drinking Cues | October 2008 | January 2010 |
| NCT00874003 | Completed | Phase 2 | The Effects of Mirtazapine Versus Placebo on Alcohol Consumption in Male Alcohol High Consumers | April 2004 | February 2009 |
| NCT00877734 | Completed | Phase 2/Phase 3 | Efficacy and Tolerability of Baclofen for Alcohol Dependence | April 2005 | June 2007 |
| NCT00884884 | Completed | Phase 2/Phase 3 | Aripiprazole and Topiramate on Free-Choice Alcohol Use | September 2007 | October 2015 |
| NCT00896038 | Completed | Phase 2 | The Effect of NK1R Antagonism on Alcohol Craving and PTSD Symptoms in Alcohol Dependent Patients With PTSD | May 2009 | August 2014 |
| NCT00920829 | Completed | Phase 4 | Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism | June 2009 | December 2015 |
| NCT00923923 | Completed | N/A | Stress Reactivity in Veterans Receiving Pharmacological Treatment for PTSD and Alcohol Dependence | January 2009 | July 2015 |
| NCT00929344 | Completed | Phase 2 | Duloxetine Versus Pregabalin for Alcohol Dependence | July 2009 | October 2014 |
| NCT00981617 | Completed | Phase 2 | ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence | October 2009 | August 2010 |
| NCT01002105 | Completed | Phase 4 | Baclofen as Add-On to Standard Treatment of Alcohol- Dependent Patients | January 2010 | December 2012 |
| NCT01003119 | Completed | N/A | Computer-Based Alcohol Use Disorder Recovery System | February 2009 | October 2012 |
| NCT01014533 | Completed | N/A | Pharmacotherapy and Mechanisms of Sleep Disturbance in Alcohol Dependence | May 2007 | September 2011 |
| NCT01015586 | Completed | Phase 4 | Treatment of Alcohol Dependence and Comorbid Bipolar Disorder | February 2010 | September 2014 |
| NCT01055171 | Completed | Phase 2 | Neuromodulation of Trauma Memories in PTSD & Alcohol Dependence | January 2010 | August 2012 |
| NCT01056484 | Completed | Phase 2 | Mindfulness Meditation for Health | September 2009 | May 2013 |
| NCT01060397 | Completed | N/A | A Controlled Trial of Extended Brief Interventions in Alcohol Dependent Patients | November 2009 | November 2013 |
| NCT01077310 | Completed | N/A | Alcohol Pharmacotherapy for HIV+ Prisoners | August 2010 | August 2015 |
| NCT01093716 | Completed | N/A | Anti-craving Efficacy of Right and Left Prefrontal High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Alcohol Dependence | August 2009 | February 2010 |
| NCT01114919 | Completed | N/A | Helping Problem Drinkers on the Internet | May 2010 | |
| NCT01120080 | Completed | Phase 1/Phase 2 | Alcohol Counseling for Telephone Quitline Callers | January 2011 | May 2012 |
| NCT01128140 | Completed | Phase 2 | Efficacy Trial of Warrior Check-Up | October 2010 | September 2014 |
| NCT01135654 | Completed | N/A | Alcohol Drinking as a Vital Sign | January 2010 | December 2018 |
| NCT01141049 | Completed | Phase 2/Phase 3 | Gabapentin for Abstinence Initiation in Alcohol Dependence | August 2010 | December 2012 |
| NCT01145677 | Completed | Phase 2/Phase 3 | Efficacy of Topiramate for Hospitalized Patients With Alcoholism | June 2010 | June 2011 |
| NCT01151813 | Completed | Phase 2 | Human Behavioral Pharmacology Laboratory (HBPL) Study of Varenicline's Impact on Cocaine and Alcohol Craving | July 2010 | December 2013 |
| NCT01165541 | Completed | Phase 2 | A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency | September 2010 | October 2012 |
| NCT01168960 | Completed | Phase 4 | Identifying Multiple Mechanisms of Change in Alcoholism Treatment | January 2010 | August 2012 |
| NCT01171677 | Completed | N/A | Impact of Exercise and Affirmations (IntenSati) on Addiction-related Cognitive and Psychosocial Deficits | July 2010 | November 2010 |
| NCT01176591 | Completed | Phase 2 | HBPL Study of the Impact of the NK1 Antagonist Aprepitant | September 2010 | December 2013 |
| NCT01180829 | Completed | N/A | Pilot Study of Text Message Brief Interventions for Problem Drinkers | October 2010 | January 2012 |
| NCT01187511 | Completed | Phase 2 | CRF1 Antagonist GSK561679 in Alcoholism | January 2010 | September 2015 |
| NCT01211769 | Completed | Phase 3 | Effects of Omegas 3 and 6 on Alcohol Dependence | February 2006 | June 2008 |
| NCT01218971 | Completed | Phase 3 | ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®) | August 2002 | September 2004 |
| NCT01227980 | Completed | Phase 2 | Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^ | October 2010 | July 2014 |
| NCT01232439 | Completed | Phase 1 | A Study of Brain Receptor Occupancy in Healthy Subjects | December 2010 | April 2011 |
| NCT01254877 | Completed | Phase 2 | Ondansetron, Alcohol Use, and Alcohol-Related Symptoms In HIV+ Persons | December 2010 | January 2017 |
| NCT01262287 | Completed | Phase 4 | Dutasteride for the Reduction of Alcohol Use in Male Drinkers | January 2011 | December 2012 |
| NCT01266655 | Completed | Phase 2/Phase 3 | Baclofen for the Treatment of Alcohol Dependence | February 2011 | May 2014 |
| NCT01292057 | Completed | Phase 3 | Aripiprazole Effects on Alcohol Drinking and Craving | February 2011 | December 2015 |
| NCT01296646 | Completed | Phase 2 | Sweet Preference and Alcohol Craving | January 2010 | June 2012 |
| NCT01312129 | Completed | N/A | Effects of Sulfasalazine on BOLD Response to Alcohol Cues | March 2010 | September 2011 |
| NCT01330394 | Completed | Phase 2 | Transcranial Direct Current Stimulation Over Dorsolateral Prefrontal Cortex in Alcoholism | June 2011 | July 2013 |
| NCT01338506 | Completed | N/A | Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use Disorders | April 2011 | March 2016 |
| NCT01342549 | Completed | Phase 3 | Treatment Strategy for Alcohol Use Disorders in Veterans With TBI | September 2011 | June 2015 |
| NCT01347112 | Completed | Phase 2/Phase 3 | Varenicline Treatment for Active Alcoholic Smokers | June 2011 | March 2014 |
| NCT01382316 | Completed | Phase 3 | Making Alcoholics Anonymous Easier | July 2005 | August 2007 |
| NCT01409707 | Completed | N/A | Mechanisms of Change, Motivation, and Treatment Outcome in Alcohol Dependence - Posttraumatic Stress Disorder | July 2008 | May 2013 |
| NCT01437046 | Completed | Phase 2 | Doxazosin an a1 Antagonist for Alcohol Dependence | November 2011 | March 2015 |
| NCT01449981 | Completed | N/A | Development and Testing of Adolescent Twelve-Step Facilitation | October 2011 | January 2016 |
| NCT01491347 | Completed | Brain Derived Neurotrophic Factor Serum Levels Evolution During the Six Months After Alcohol Withdrawal | November 2011 | December 2016 | |
| NCT01503931 | Completed | Endophenotyping With Functional Magnetic Resonance Imaging (fMRI) | June 2008 | June 2013 | |
| NCT01534494 | Completed | Phase 2 | Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence | January 2012 | March 2014 |
| NCT01551329 | Completed | Phase 1 | Ketamine for Depression and Alcohol Dependence | March 2012 | November 2015 |
| NCT01613014 | Completed | Phase 2 | ABT-436 for Alcohol Dependence | February 2013 | July 2015 |
| NCT01657760 | Completed | Phase 1 | Citalopram Effects on Craving and Dopamine Receptor Availability in Alcoholics | May 1, 2014 | September 1, 2017 |
| NCT01711125 | Completed | Phase 3 | Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease | March 2013 | June 2017 |
| NCT01719497 | Completed | Imaging of Cannabinoid 1 Receptors Using [11C]OMAR and PET | June 2009 | May 2014 | |
| NCT01738282 | Completed | Phase 3 | Efficacy and Safety of Baclofen for Maintenance of Abstinence in Alcohol Dependent Patients | December 2012 | July 2014 |
| NCT01749215 | Completed | Phase 4 | A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD | February 2013 | July 2019 |
| NCT06173973 | Enrolling by invitation | Phase 2/Phase 3 | Effects of Ketone Supplementation on Acute Alcohol Withdrawal | March 11, 2024 | December 2027 |
| NCT04897295 | Not yet recruiting | N/A | Neurobiological Effects of Transcranial Direct Current Stimulation Treatment in Alcohol Use Disorder | December 1, 2021 | November 30, 2026 |
| NCT06265506 | Not yet recruiting | N/A | Virtual Incentive Treatment for Alcohol | February 19, 2024 | April 4, 2028 |
| NCT05620940 | Not yet recruiting | Phase 1 | A Clinical Trial to Assess Pharmacokinetic Profiles and Safety of IVL3004 | October 1, 2023 | March 31, 2024 |
| NCT06444243 | Not yet recruiting | Phase 2 | Psilocybin-assisted Therapy for Alcohol Use Disorder | September 2024 | December 2025 |
| NCT06405607 | Not yet recruiting | Phase 2 | Psilocybin vs Ketamine for Alcohol Use Disorder | June 2024 | June 2027 |
| NCT06419647 | Not yet recruiting | N/A | Tracking Mood: The Effects of Daily Mood Tracking VAS on Alcohol Consumption in Adult Heavy Drinkers | May 2024 | December 2025 |
| NCT04164940 | Recruiting | Patient Trajectories for Older Adults Admitted to Hospital for Alcohol-related Problems | October 23, 2019 | December 2030 | |
| NCT05963659 | Recruiting | N/A | Nitrate Modulates Cognitive Impairment Via Oral Microbiota. | September 10, 2023 | August 7, 2024 |
| NCT05895643 | Recruiting | Phase 2 | Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity? | June 13, 2023 | March 2027 |
| NCT05854693 | Recruiting | N/A | Trans-cranial Direct Current Stimulation on Alcohol Craving | April 17, 2023 | June 2026 |
| NCT00439049 | Recruiting | Substance Abuse Pre-Treatment Screening Study | October 2005 | June 2026 | |
| NCT05747703 | Recruiting | N/A | Telehealth Treatment for Alcohol Use Disorder | January 31, 2024 | September 2025 |
| NCT05738174 | Recruiting | N/A | High-dose Accelerated Theta Burst Stimulation for the Treatment of Alcohol Addiction | March 1, 2023 | March 31, 2025 |
| NCT05709353 | Recruiting | Phase 2 | MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder | September 19, 2023 | May 2026 |
| NCT04490330 | Recruiting | Screening for Alcohol-related Cognitive Impairments in Cirrhotic Patients | August 1, 2020 | August 2023 | |
| NCT06308484 | Recruiting | N/A | Neuromodulation and Mindfulness Patients With AUD | March 20, 2024 | June 30, 2027 |
| NCT06333457 | Recruiting | Presence and Relapse Rates in Patients With Alcohol Use Disorder Using Virtual Reality | April 1, 2024 | February 1, 2025 | |
| NCT02108080 | Recruiting | Characterization Imaging Instruments in Alcoholics and Non-Alcoholics | July 10, 2014 | December 31, 2025 | |
| NCT04743024 | Recruiting | TREAT Child Alcohol Use Disorder (C-AUD) in Eastern Uganda | December 27, 2020 | July 31, 2025 | |
| NCT04154111 | Recruiting | N/A | Theta Burst Stimulation as a Tool to Decrease Drinking in Treatment-seeking Alcohol Users | May 26, 2020 | August 2025 |
| NCT02108054 | Recruiting | N/A | Behavioral and Functional Task Development, Implementation, and Testing | May 28, 2014 | December 31, 2025 |
| NCT06262958 | Recruiting | N/A | Recognition and Early Intervention for Alcohol and Substance Abuse in Adolescence in Adolescent | August 7, 2017 | June 1, 2030 |
| NCT04014413 | Recruiting | N/A | Safety and Efficacy of Fecal Microbiota Transplantation | July 15, 2019 | October 31, 2030 |
| NCT00425711 | Terminated | N/A | Study of Acamprosate in Driving Under the Influence (DUI) Court Participants | February 2007 | December 2009 |
| NCT00461890 | Terminated | Phase 4 | Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial | October 2006 | December 2007 |
| NCT04280068 | Terminated | N/A | Targeting Non-virally Suppressed Adults With Alcohol Use Disorder in HIV Primary Care | March 2, 2020 | June 30, 2020 |
| NCT02771925 | Terminated | Phase 4 | Treatment for Alcohol Dependence With Gabapentin | June 2016 | May 16, 2018 |
| NCT01155869 | Terminated | Phase 4 | Pilot Study of Depot NTX in Homeless Veterans | August 2010 | June 2012 |
| NCT02881424 | Terminated | Study of Familiarity in Alcohol Dependence | March 2015 | April 2018 | |
| NCT03056365 | Terminated | N/A | Advanced Nurses vs. General Practitioners for the Management of Outpatient Alcohol Detox: a Safety and Cost Comparison | January 1, 2017 | February 1, 2021 |
| NCT02195817 | Terminated | Phase 4 | Study of 18 mg Selincro® As-needed Use, in the Treatment of Patients With Alcohol Dependence in Primary Care | August 2014 | February 2016 |
| NCT01408641 | Terminated | N/A | Topiramate for Alcohol Use in Posttraumatic Stress Disorder | September 2012 | August 2013 |
| NCT00835718 | Terminated | Phase 2 | A Study of MK0594 in Patients With Alcohol Dependence (0594-020) | February 27, 2009 | March 11, 2010 |
| NCT00249379 | Terminated | Phase 4 | Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice Supervisees | June 2005 | August 2008 |
| NCT01631630 | Terminated | Phase 2 | Role of Proinflammatory Signaling in Alcohol Craving | May 2012 | September 2015 |
| NCT00862563 | Terminated | Phase 2 | Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism | May 2009 | August 2013 |
| NCT01638377 | Terminated | Phase 4 | Pharmacotherapy for Alcohol Dependence in Convicted Drinking Drivers | August 2012 | March 2014 |
| NCT02472483 | Terminated | N/A | Effectiveness of TCC Followed by MBCT and Predictive Factors (Genetic, Clinical and Cognitive) Response | September 13, 2012 | September 13, 2019 |
| NCT01764685 | Terminated | Phase 2 | Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers | January 2013 | January 2014 |
| NCT03204214 | Unknown status | Binge Drinking And Addiction : Case-Control Study in Hospital | April 1, 2016 | July 31, 2018 | |
| NCT02385643 | Unknown status | N/A | The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients | September 2013 | July 2017 |
| NCT01812187 | Unknown status | N/A | Designing a Mobile App for Veterans With Substance Use Problems | April 2015 | May 2017 |
| NCT00448825 | Unknown status | Phase 3 | Novel Pharmacotherapy for Dual Dependence | March 2007 | June 2013 |
| NCT04054336 | Unknown status | N/A | The Approach and Avoidance Task (AAT) in Alcoholic Inpatients | February 2, 2017 | August 31, 2020 |
| NCT03879759 | Unknown status | Phase 2 | The Efficacy and Neurobehavioural Mechanism of N-acetyl Cysteine (NAC) for Alcohol Dependence | August 22, 2018 | November 2020 |
| NCT01663337 | Unknown status | N/A | Sequence of Symptom Change During AUD or PTSD Treatment for Comorbid PTSD/AUD | March 2013 | January 2019 |
| NCT01182766 | Unknown status | Phase 2/Phase 3 | New Treatment for Alcohol and Nicotine Dependence | September 2011 | June 2022 |
| NCT04876443 | Unknown status | Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD) | October 8, 2020 | July 31, 2022 | |
| NCT00183157 | Unknown status | Phase 2 | Project RAP: Reaching Adolescents for Prevention | October 2004 | December 2009 |
| NCT03910686 | Unknown status | N/A | Efficacy of Repetitive Transcranial Magnetic Stimulation and Cognitive Behavioral Therapy on Alcohol Dependence | June 30, 2019 | December 2021 |
| NCT03235531 | Unknown status | Phase 4 | Assessment of Valproate on Ethanol Withdrawal | July 11, 2017 | January 1, 2020 |
| NCT00570388 | Unknown status | N/A | Neurocognitive Functioning Following The PROMETA® Treatment Protocol In Subjects With Alcohol Dependence | March 2007 | September 2008 |
| NCT01135602 | Unknown status | Phase 4 | Topiramate for Hospitalized Patients With Alcoholism: a 12-week Study | July 2010 | March 2012 |
| NCT01115894 | Unknown status | Phase 3 | Medication and Counseling for Controlled Drinking | February 2007 | |
| NCT04205682 | Unknown status | Early Phase 1 | Cannabidiol (CBD) for the Treatment of Alcohol Withdrawal | January 2020 | January 2021 |
| NCT03479086 | Unknown status | Phase 3 | Defining the Clinical Role of Topiramate in the Treatment of Alcohol Dependence in Australia | June 20, 2017 | November 1, 2020 |
| NCT00280488 | Unknown status | Phase 3 | Enhanced Motivational Interviewing With Alcohol Positive Trauma Patients | May 2005 | April 2011 |
| NCT00484367 | Unknown status | Phase 2/Phase 3 | A Comparison of Adolescent Group Therapy and Transitional Family Therapy for Adolescent Alcohol and Drug Abusers | July 1999 | August 2012 |
| NCT03589118 | Unknown status | N/A | Qi Gong as a Method of Craving Reduction in Severe Addict Patients | October 4, 2018 | December 2020 |
| NCT01071187 | Unknown status | Phase 2 | Varenicline for Alcohol Dependence | March 2010 | September 2011 |
| NCT03952429 | Unknown status | N/A | A Smartphone Based Intervention for the Prevention of Relapse in Alcohol Dependence | May 23, 2019 | July 31, 2022 |
| NCT00246428 | Unknown status | Phase 3 | Motivational Interviewing for Alcohol-Positive Teens in the Emergency Room | January 2000 | July 2003 |
| NCT02181608 | Withdrawn | Traits Associated With Early Life Stress Among Treatment-Seeking Alcoholics | June 19, 2014 | March 24, 2015 | |
| NCT02824354 | Withdrawn | Phase 3 | Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence. | December 1, 2018 | December 1, 2022 |
| NCT04070508 | Withdrawn | Early Detection of Alcoholic Liver Disease | April 1, 2023 | November 3, 2025 | |
| NCT01853293 | Withdrawn | Phase 2 | Use of Kudzu Extract in the Study of Its Ability to Reduce Alcohol Drinking in Treatment Seeking Alcohol Dependent Persons | March 2014 | |
| NCT01719458 | Withdrawn | Norepinephrine Transporter Imaging in Addiction Disorders | July 2007 | January 4, 2023 | |
| NCT00655967 | Withdrawn | Phase 4 | Safety of Acamprosate for Alcohol Dependence in the Elderly: An Open-Label Study (SAFADIE) | December 2006 | December 2006 |
| NCT05275166 | Withdrawn | N/A | Study of the Neural Substrates of Alcohol Craving by High-resolution Electroencephalography | May 2023 | November 2025 |
| NCT00571246 | Withdrawn | Phase 3 | The Use of Anticonvulsants for Treatment of Patients With Alcohol Dependence and Post Traumatic Stress Disorder | June 2012 | June 2016 |
| NCT00908206 | Withdrawn | Phase 1 | Effects of GSK598809 on Brain Activation in Abstinent Alcoholics | May 2009 | July 2009 |
| NCT00622921 | Withdrawn | Phase 2/Phase 3 | Couples-based Behavioral Psychotherapy for Male Patients With Posttraumatic Stress Disorder and Alcohol Dependence | February 2008 | February 2012 |
| NCT00463775 | Withdrawn | Phase 3 | Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence | March 2007 | May 2009 |
- Disase is a (Disease Ontology)
- DOID:9973
- Cross Reference ID (Disease Ontology)
- KEGG:05034
- Cross Reference ID (Disease Ontology)
- MIM:103780
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2021_09_01:66590003
- Exact Synonym (Disease Ontology)
- alcoholism